Thatcher Heumann

622 total citations
30 papers, 255 citations indexed

About

Thatcher Heumann is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Thatcher Heumann has authored 30 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Immunology and 9 papers in Surgery. Recurrent topics in Thatcher Heumann's work include Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Immunotherapy and Immune Responses (8 papers). Thatcher Heumann is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Immunotherapy and Immune Responses (8 papers). Thatcher Heumann collaborates with scholars based in United States and Germany. Thatcher Heumann's co-authors include Nilofer S. Azad, Rajiv Agarwal, Laura W. Goff, Christopher J. Hogan, David A. Ingram, Vivek Balasubramaniam, Gregory Seedorf, Sharon Ryan, Neil Markham and Steven H. Abman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Thatcher Heumann

30 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thatcher Heumann United States 8 113 96 94 49 44 30 255
Yoshinari Matsuda Japan 11 81 0.7× 132 1.4× 89 0.9× 62 1.3× 37 0.8× 22 314
Yogesh Kembhavi India 6 117 1.0× 114 1.2× 57 0.6× 27 0.6× 147 3.3× 11 371
Zaher Chakhachiro Lebanon 10 101 0.9× 69 0.7× 41 0.4× 28 0.6× 64 1.5× 26 199
Remo Vernillo Italy 12 217 1.9× 75 0.8× 70 0.7× 59 1.2× 14 0.3× 19 366
Susumu Hirosako Japan 9 32 0.3× 107 1.1× 165 1.8× 69 1.4× 70 1.6× 29 319
Daniela Sambataro Italy 7 123 1.1× 76 0.8× 40 0.4× 35 0.7× 31 0.7× 22 240
Christiana Brenin United States 7 101 0.9× 124 1.3× 122 1.3× 43 0.9× 19 0.4× 16 291
Lucía González‐Cortijo Spain 11 94 0.8× 108 1.1× 84 0.9× 72 1.5× 59 1.3× 26 434
Monika Šedivcová Czechia 10 59 0.5× 120 1.3× 38 0.4× 53 1.1× 39 0.9× 18 222
Alesha A. Thai Australia 9 48 0.4× 230 2.4× 92 1.0× 55 1.1× 71 1.6× 16 316

Countries citing papers authored by Thatcher Heumann

Since Specialization
Citations

This map shows the geographic impact of Thatcher Heumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thatcher Heumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thatcher Heumann more than expected).

Fields of papers citing papers by Thatcher Heumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thatcher Heumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thatcher Heumann. The network helps show where Thatcher Heumann may publish in the future.

Co-authorship network of co-authors of Thatcher Heumann

This figure shows the co-authorship network connecting the top 25 collaborators of Thatcher Heumann. A scholar is included among the top collaborators of Thatcher Heumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thatcher Heumann. Thatcher Heumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eghbali, Shabnam & Thatcher Heumann. (2025). Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches. Cancers. 17(2). 236–236. 6 indexed citations
2.
Holowatyj, Andreana N., Deepa Magge, Deborah Shelton, et al.. (2025). The presenting symptoms of patients with appendiceal malignant tumors.. Journal of Clinical Oncology. 43(4_suppl). 824–824. 1 indexed citations
3.
Heumann, Thatcher, Michael Cecchini, Raid Aljumaily, et al.. (2024). A phase I study of irinotecan combined with BAY1895344 (ATR inhibitor) in advanced solid tumors: Results of ETCTN 10402 dose escalation.. Journal of Clinical Oncology. 42(16_suppl). 3077–3077. 1 indexed citations
4.
Heumann, Thatcher, Mark Yarchoan, Jiayun Lu, et al.. (2024). A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer.. Journal of Clinical Oncology. 42(16_suppl). 4017–4017. 3 indexed citations
5.
Cecchini, Michael, Raid Aljumaily, Þorvarður R. Hálfdánarson, et al.. (2024). A phase I study of ATR inhibitor BAY1895344 (elimusertib) plus topotecan (ETCTN 10402): Results of dose escalation.. Journal of Clinical Oncology. 42(16_suppl). 3076–3076. 3 indexed citations
6.
Agarwal, Rajiv, et al.. (2024). Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma. Current Treatment Options in Oncology. 25(1). 127–160. 7 indexed citations
7.
Agarwal, Rajiv, et al.. (2024). Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma. PubMed. 4(1). 247–262. 1 indexed citations
8.
Lo, Justin H., Rajiv Agarwal, Laura W. Goff, & Thatcher Heumann. (2023). Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies. Cancers. 15(13). 3312–3312. 25 indexed citations
9.
Heumann, Thatcher, Mark Yarchoan, Hao Wang, et al.. (2023). ETCTN 10476: A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer.. Journal of Clinical Oncology. 41(4_suppl). TPS639–TPS639. 3 indexed citations
10.
Heumann, Thatcher, et al.. (2023). Targeted therapies in advanced biliary tract cancers—a narrative review. Chinese Clinical Oncology. 12(2). 14–14. 7 indexed citations
11.
Montagne, Janelle M., Thomas R. Nirschl, Emily F. Davis-Marcisak, et al.. (2023). Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses. Cell Reports Methods. 3(10). 100600–100600. 1 indexed citations
12.
Iyer, Renuka, Nainesh Parikh, Richard D. Kim, et al.. (2023). A phase II study of atezolizumab (ATEZO) and bevacizumab (BEV) in combination with Y90 TARE in patients (pts) with hepatocellular carcinoma (HCC): Y90+/- BEAT.. Journal of Clinical Oncology. 41(4_suppl). TPS629–TPS629. 3 indexed citations
13.
Heumann, Thatcher, Karisa C. Schreck, John Gross, et al.. (2022). BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report. SHILAP Revista de lepidopterología. 15(3). 909–917. 2 indexed citations
14.
Heumann, Thatcher & Nilofer S. Azad. (2021). Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance. Cancer and Metastasis Reviews. 40(3). 837–862. 17 indexed citations
15.
Heumann, Thatcher & Nilofer S. Azad. (2021). Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance. Cancer and Metastasis Reviews. 40(3). 863–864. 3 indexed citations
16.
Thummalapalli, Rohit, Thatcher Heumann, Julie E. Stein, et al.. (2020). Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma. Case Reports in Oncology. 13(2). 508–514. 14 indexed citations
17.
Heumann, Thatcher, Kyle T. Bradley, Jeffrey M. Switchenko, et al.. (2016). CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation. Dermatology and Therapy. 6(2). 251–263. 4 indexed citations
18.
Heumann, Thatcher, Natia Esiashvili, Sareeta Parker, et al.. (2015). Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma Using a Modern Dual-Field Rotational Technique. International Journal of Radiation Oncology*Biology*Physics. 92(1). 183–191. 32 indexed citations
19.
Balasubramaniam, Vivek, Sharon Ryan, Gregory Seedorf, et al.. (2009). Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 298(3). L315–L323. 75 indexed citations
20.
Neeße, Albrecht, James F. Huth, Thatcher Heumann, et al.. (2008). Echo-Rich and Echo-Poor Periportal Cuffing: Pole Position for Inflammatory Bowel Diseases. Ultraschall in der Medizin - European Journal of Ultrasound. 29(6). 633–638. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026